News | November 17, 2021
Sluggish exports to cap pharma revenue growth at 9% this fiscal
A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.
A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.
The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards
The 50,000 square foot expansion will house a high-speed filling line and lyophilizers, which will increase the facility’s sterile injectable capacity by 50%
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
The NFI is published to promote the rational use of medicines in the country.
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Subscribe To Our Newsletter & Stay Updated
